The Ulthera System has not been evaluated for use in patients on an
anticoagulant treatment plan.
It is recommended that the following areas should be avoided during
treatment:
Thyroid gland, thyroid cartilage and trachea
•
Major vessels
•
Breast tissue or breast implants
•
The Ulthera System has not been evaluated for use in the following patient
populations:
Pregnant or breast feeding women
•
Children
•
Those with the following disease states
•
o A hemorrhagic disorder or hemostatic dysfunction
o An active systemic or local skin disease that may alter wound
o Herpes Simplex
o Autoimmune Disease
o Diabetes
o Epilepsy
o Bell's Palsy
2.4. Patient Safety
W arning: Ulthera should not be used on a patient's eyes or in a location
or technique where ultrasound energy can reach the eye.
W arning: Use this system only if you are trained and qualified to do so.
W arning: If any problems occur during system operation, take
immediate action(s): lift the transducer off the patient's skin, press the
See pushbutton on handle to discontinue treatment in progress, and/or
press the red emergency Stop button to completely halt system
operation.
Ulthera, Inc.
healing
9
Page